PetMed Express Q2 net loss of $70k; suspends quarterly dividend to invest in growth

PETMED EXPRESS INC

2024-Q2 EPS reported -$0.05 revenue$149,243,000

Net sales $71.0M (+9% YoY); net loss $70k vs $2.6M income; diluted EPS ($0.00) vs $0.13.
Adjusted EBITDA $3.2M, down 55% from $7.1M, citing acquisition costs and strategic investments.
Board suspends quarterly dividend, shifting capital allocation to organic and inorganic growth initiatives.
New customers up 25% YoY; AutoShip & Save and PetPlus programs account for 51% of revenue, up from 39%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

PETMED EXPRESS INC reported its second quarter ended September 30, 2023 results: revenue $71.0 million, net income Net loss for the quarter ended September 30, 2023 was $70 thousand, or $(0.00) per diluted share, EPS $(0.00) per diluted share.

Period: its second quarter ended September 30, 2023
Revenue: $71.0 million
Net income: Net loss for the quarter ended September 30, 2023 was $70 thousand, or $(0.00) per diluted share
EPS: $(0.00) per diluted share
Result: reported results

Exact text from the filing

TM , today announced its financial results for its second quarter ended September 30, 2023. Quarterly Highlights • Net sales for the quarter ended September 30, 2023, were $71.0 million, compared to $65.4 million for the second quarter in the prior year, an increase of 9% year over year. The current quarter includes the results from the recent acquisition of

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-23-000078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.